Updated: Sunday January 01, 2017/AlAhad
Rabi' Thani 03, 1438/Ravivara
Pausa 11, 1938, at 03:02:58 PM
[1]The
(Act XLVI of 2016)
[29 October 2016]
An Act to regulate collection, testing,
processing, storage, distribution, issuance, transfusion of human blood, blood
components, ensuring health protection and prevention of transfusion
transmissible diseases.
It is necessary to regulate the collection,
testing, processing and storage of human blood and blood components, as well as
the rational use of safe blood and its products whenever intended for
transfusion; and, to deal with ancillary matters.
Be it enacted by Provincial Assembly of the
1. Short title, extent and
commencement.– (1) This Act
may be cited as the Punjab Blood Transfusion Safety Act 2016.
(2) It
extends to whole of the
(3) It
shall come into force at once.
2. Definitions.–In
this Act:---
(a) “Act”
means the Punjab Blood Transfusion Safety Act 2016;
(b) “Authority”
means Punjab Blood Transfusion Authority constituted under the Act;
(c) “autologous
donation” means that donor and recipient are the same;
(d) “blood”
means whole blood collected from a donor;
(e) “blood
center” means any structure or a body which manufactures blood and blood
components; and, performs collection, testing, processing, storage, and distribution
of blood and blood components to the hospital blood banks;
(f) “blood
component” means a therapeutic constituent of blood including red cells, white
cells, platelets, plasma, cryoprecipitate andcryosupernatant prepared by
various methods;
(g) “blood
establishment” means any facility carrying out one or more of the processes in
the blood transfusion chain;
(h) “blood
product” means any therapeutic product derived from human blood or plasma such
as albumin, factor concentrates, prothrombin complex concentrates;
(i) “deferral”
means temporary or permanent suspension of the eligibility of an individual to
donate blood or blood components;
(j) “distribution”
means an act of delivery of blood or blood components to other
blood centres, hospital blood banks and manufacturers of blood and plasma
derived products but shall not include the issuance of blood or blood
components for transfusion;
(k) “donor”
means a person who, by his free will and without compensation or payment, donates
blood or a part of his blood such as plasma or cellular components for use in
the medical treatment or for scientific research;
(l) “Government”
means Government of the
(m) “haemovigilance” means
a continuous process of data collection and analysis of transfusion-related
adverse events and reactions, conducted to investigate their causes and
outcomes, to prevent their occurrence or recurrence throughout the blood
transfusion chain, and to increase the safety, efficacy and efficiency of blood
transfusion, but haemovigilance shall be dependent on the
traceability of blood and blood products from donors to recipients
and vice versa (bi-directional tracking);
(n) “hospital
blood bank” means a hospital unit which receives and stores screened blood and
blood components received from a blood centre, performs compatibility testing
and issues blood and blood components for clinical use;
(o) “inspection”
means an official, formal and objective inspection based on the adopted
standards to assess and measure the non-compliance of the Act, rules and
regulations;
(p) “Inspector”
means a blood safety inspector appointed under section 9 of the Act;
(q) “issuance”
means the provision of blood or blood components by a hospital blood bank, or
specialized blood transfusion service for transfusion to a recipient;
(r) “non-compliance”
means deviation from the standards prescribed by or under the Act or the
Authority, as the case may be, and shall include:
(i) critical
non-compliance that directly affects the safety of a recipient or donor; or
(ii) serious non-compliance that on
its own does not directly affect the safety of a recipient or donor; or
(iii) significant non-compliance for which there
is insufficient information to classify it as critical or serious
non-compliance;
(s) “offence”
includes a critical and significant offence as prescribed under section 18 of
the Act;
(t) “prescribed”
means prescribed by the rules or regulations made under the Act;
(u) “processing”
means any step in the preparation of a blood component carried out
between the collection of blood and its storage;
(v) “recipient”
means a person who receives transfusion of blood or blood components;
(w) “responsible
person” means a person accountable for ensuring that every unit of blood or
blood components has been collected, tested, processed, stored, distributed and
issued in compliance with the provisions of the Act, rules or regulations made
thereunder;
(x) “safe
blood” means the blood which is safe for both the donor and the recipient;
(y) “screened
blood” means human blood or blood products which, based on established testing
methods, has been tested negative for HIV, Hepatitis B and Hepatitis C viruses
or other viruses or infective agents, like malarial parasites
and treponema pallidum (syphilis) or such other viruses or infective
agents as the Authority may specify;
(z) “Secretary”
means the Secretary of the Authority;
(aa) “serious
adverse event” means an untoward occurrence associated with the collection,
testing, processing, storage and distribution of blood and blood components
that might lead to death or life-threatening, disabling or incapacitating
conditions for the patients or which results in or prolongs hospitalization or
morbidity;
(bb) “serious
adverse reaction” means an undesirable response or effect in a donor or in a
patient associated with the collection or administration of blood or blood
components which is fatal, life-threatening, disabling, incapacitating, or
which results in or prolongs hospitalization or morbidity;
(cc) “traceability”
means the capacity of a blood transfusion system to trace blood and blood
components from the donor to its final destinationand vice
versa (bi-directional tracking); and
(dd) “unhygienic”
means anything or atmosphere harmful to donor, blood, reagents or equipment.
3. Authority.– (1) The Government may, by notification,
establish the Authority to be known as Punjab Blood Transfusion Authority.
(2) The Authority shall be a body
corporate, having perpetual succession and a common seal with power to
acquire, hold and dispose of property and shall by the said name sue and be
sued.
(3) The Authority shall consist of the
following:---
|
(a) |
three members, including at least one female member,
of Provincial Assembly of the |
|
(b) |
Additional Secretary (Technical) to the Government,
Specialized Healthcare and Medical Education Department; |
|
(c) |
Director General Health, |
|
(d) |
Director, |
|
(e) |
Four professors, including at least one female
Professor of Medicine, Surgery and Hematology or Transfusion Medicine; |
|
(f) |
Commandant, Combined |
|
(g) |
Director General of |
|
(h) |
a representative of the blood donor
organizations, to be nominated by the Authority. |
(4) A
member, other than an ex-officio member, shall hold office for
a period of three years from the date of assuming office but the
Government may extend the term of a member for such period as it may deem
necessary.
(5) The
Government shall nominate the Minister for Health or Advisor to Chief Minister
for Health as the Chairperson of the Authority and determine the terms and
conditions of such appointment.
(6) In
case of a casual vacancy in the Authority, the Government shall nominate a new
member for the remaining term of the outgoing member.
4. Functions of the Authority.– (1) The Authority shall:---
(a) be responsible for the
general administration, supervision, superintendence and management of the affairs
of the Authority;
(b) approve polices and schemes;
(c) regulate all matters
relating to blood transfusion throughout the
(d) ensure that the standards and
specifications shall, at least, cover:
(i) the
registration and licensing of blood establishments;
(ii) standards
for processes performed by blood establishments;
(iii) specifications
and quality control requirements of blood and blood components;
(iv) storage
and transportation of blood and blood components;
(v) traceability
and haemovigilance;
(vi) motivation
of blood donors;
(vii) autologous donation
and transfusion;
(viii) imparting relevant information
to donors and obtaining from them appropriate information such as identification,
health history and signature of the donor;
(ix) determining
the requirements concerning the suitability of donors of blood and blood
components;
(x) screening
of donated blood including deferral criteria and possible exemption thereto;
and
(xi) procedures
for notifying serious adverse reactions and events, notification format and
guidelines on optimal clinical use of blood;
(e) ensure
that any serious adverse events related to the collection, testing, processing,
storage and distribution, issuance or administration of blood and blood
components, which may have an influence on the quality and safety of blood and
blood components or on donor and staff safety, as well as any serious adverse
reactions observed in donors that may be attributed to the donation or in
patients that may be attributed to the transfusion are notified to the
Authority;
(f) take all
necessary measures to ensure that blood and blood components collected, tested,
processed, stored, released, distributed or issued are traced from donor to
recipient and vice versa;
(g) take all
necessary measures to ensure that the system used for the labeling of blood and
blood components complies with the identification system;
(h) manage and
report data for planning, implementation and evaluation of services;
(i) take
all necessary measures to ensure that access is provided to documents
(operational procedures, guidelines, training, reference manuals and reporting
forms) to the officials entrusted with inspections and control measures;
(j) hold
regular meetings with the bodies designated by the Government, delegations of
experts and other relevant parties to exchange information on the experience
acquired with regard to the implementation of the Act;
(k) register blood
establishments, categorize them indicating which processes the blood
establishments are entitled to perform, issue licenses, and, subject to the
fulfillment of prescribed conditions, renew licenses;
(l) regulate
matters relating to the meetings of the Authority; and
(m) perform such other
functions as may be prescribed.
(2) The
Authority may:---
(a) suspend or
revoke the license of a person if any condition of the license or any
provisions of the Act, rules or regulations has been infringed;
(b) prescribe minimum
standards and specifications for registration and licensing;
(c) collaborate with
other institutions, professional bodies and experts;
(d) take all
necessary measures to ensure that each blood establishment establishes and
maintains a quality management system as prescribed by the Authority;
(e) set
up minimum requirements for record keeping of blood establishments and keep
records of the data received from the blood establishments with regard to
registration and licensing, inspections, responsible person and notification of
serious adverse reactions and events; and
(f) organize inspections
and appropriate control measures in blood establishments, to make certain that
the requirements of the Act, and any rules, regulations, and standards
hereunder, are complied with.
5. Secretary.– (1) The Government shall appoint the Secretary
of the Authority on such term and conditions as it may determine or as may be
prescribed.
(2) The
Secretary shall be the Chief Executive Officer of the Authority and shall
exercise such powers as may be prescribed or as are delegated to him by the
Authority.
(3) A
person shall not be appointed as Secretary if he is a director, officer or
employee of any healthcare service provider or has an interest or share in any
blood establishment.
6. Technical
Committee.– (1) The Authority
shall, for a specified period, constitute the Technical Committee, consisting
of the following:---
|
(a) |
Additional Secretary (Technical) to the Government,
Specialized Healthcare and Medical Education Department; |
|
(b) |
Director, |
|
(c) |
Two Professors of Haematology; |
|
(d) |
a representative of the blood donor organizations,
to be nominated by the Authority; and |
|
(e) |
a legal expert. |
(2) The Authority shall nominate the
convener of the Technical Committee from amongst its members.
(3) The Technical Committee shall provide
advice on any matter referred to it by the Authority including matters related
to blood transfusion standards and quality assurance.
7. Licensing
Board.– (1) There shall be a
Licensing Board consisting of the following:---
(a) Secretary;
(b) one haematologist; and
(c) one other technical
expert nominated by the Authority for a specified period.
(2) The
Secretary shall be the convener of the Licensing Board.
(3) The
Licensing Board shall:
(a) review
all inspection reports and decide on the issuance of licenses to blood
establishments, blood centers, hospital blood banks, and specialized blood
transfusion services; and
(b) categorize non-compliances
observed as critical or significant.
(4) The
Licensing Board, in case of non-compliance or violation of the Act, rules or
regulations, may, in the manner prescribed by the Authority:
(a) refer
a case to the Inspector concerned or the local police for prosecution in the
blood safety court;
(b) direct
sealing of the premises of the blood establishment;
(c) impose
fine up to one hundred thousand rupees;
(d) order
to take into custody the blood, blood components, equipment and any other
materials being used in violation of the Act, rules or regulations;
(e) enter or
seal the blood establishment in the case of any gross violation of the Act,
rules or regulations;
(f) mark,
seal or otherwise secure any equipment or material in the case of any violation
of the Act, rules or regulations;
(g) place
a blood establishment on probation;
(h) suspend
or cancel the license of the blood establishment; and
(i) debar the
re-licensing of the blood establishment for the specified period.
8. Appellate Committee.– (1) The Government shall, for a specified
period, constitute an Appellate Committee consisting of four members, including
a Haematologist or blood transfusion expert and a legal expert.
(2) The
Government shall nominate one of the members as convener of the committee.
(3)
A person aggrieved by any decision or order of the Authority or the Licensing
Board may prefer an appeal to the Committee within fifteen days from the
communication of such decision or order.
(4)
The Committee may, after due investigation and affording opportunity of hearing
to all concerned, pass an appropriate order within thirty days.
9. Inspectors.– (1) The Government shall appoint blood
safety Inspectors in each district.
(2) An Inspector shall carry out
inspection of blood establishments and perform other functions assigned to
him by the Authority.
(3) An Inspector shall implement the
decisions of the Licensing Board, with the assistance of the local police,
if required.
(4) An Inspector shall inspect and report
an unregistered establishment to the Authority.
10. Functions of
blood centers.– (1) A blood
centre shall implement the requirements of the Act, the rules and regulations
made thereunder.
(2) A blood centre shall:---
(a) perform
processes related to the promotion of blood donations, collection, testing,
processing, storage, transport, distribution of human blood and blood
components according to the license issued;
(b) not
accept blood from paid donors and shall ensure to get blood and blood
components for transfusion through voluntary and non-remunerated blood
donations;
(c) follow
the procedures and criteria prescribed by the Authority for donor selection of
blood;
(d) follow
the criteria of permanent and temporary blood donor deferral prescribed by the Authority;
(e) communicate
the reasons for deferral to the donor through a qualified health professional
registered with the Pakistan Medical and Dental Council, and shall provide
counseling, if so required;
(f) while
performing testing of donated blood, ensure that each donation of blood and
blood components is tested for ABO and Rh blood groups and screened for HBV,
HCV, HIV, Malaria, Syphilis and any other communicable disease or such other
disease as may be prescribed;
(g) not
receive or supply blood unless it is registered and licensed under the Act;
(h) have
qualified personnel having relevant qualification from a recognized
institution for the collection, testing, processing, storage, transport and
distribution of human blood and blood components;
(i) have
a dedicated department, staff and set of equipment for the performance of each
type of processes under the license;
(j) comply with
minimum requirements for the performance regarding location, process flow,
personnel, equipment, reagents and documentation adopted and endorsed by the
Authority;
(k) submit an
annual report to the Authority in such form as may be prescribed or determined
by the Authority;
(I) notify to
the Authority the name of the responsible person and job description of other
staff working in the blood centre; and
(m) distribute blood
and blood components to a hospital, based on hospital blood bank request, and
in accordance with provisions of a written contract.
(3) The
responsible person in a blood centre shall be a qualified individual,
preferably having post-graduate qualification in blood
transfusion, haematologyor clinical pathology recognized by the Pakistan
Medical and Dental Council.
(4) Where
the responsible person in a blood centre is permanently or temporarily
replaced, the blood centre shall immediately communicate the name and other
details of the new responsible person to the Authority.
11. Functions of
hospital blood banks.– (1) Every
hospital blood bank shall observe and implement the requirements of the Act,
rules and regulations.
(2) A
hospital blood bank shall:---
(a) receive,
store and perform compatibility tests before issuance of blood and blood
components;
(b) have
qualified personnel directly involved in compatibility testing, storage,
transport and issuance of human blood and blood components;
(c) designate
a responsible person in the hospital blood bank;
(d) have
a dedicated location, staff and set of reagents and equipment for the
performance of each type of licensed processes; and
(e) ensure that
blood and blood components issued by them are transfused in a licensed medical
institution by a clinician registered with Pakistan Medical and Dental Council.
(3) The
physician shall ensure that blood and blood components being transfused are
certified as safe blood by a licensed blood establishment.
(4) The
hospital administration shall ensure rational clinical use of blood and blood
components through the hospital transfusion committee in accordance with
guidelines adopted and endorsed by the Authority.
(5) All processes performed at hospital
level in relation to transfusion therapy shall be documented in accordance with
the prescribed procedures.
12. Documentation,
record keeping and traceability.– A
blood establishment shall:---
(a) maintain
documentation on procedures, guidelines, training, reference manuals and
reporting forms;
(b) maintain
records of the information obtained from donors, including their
identification, health history, temporary and permanent deferral and signature;
total number of donors and donations; whole blood donations not used; number of
every blood component produced and distributed, as well as screening results of
the donated blood;
(c) keep
the record safe for a minimum of fifteen years; and
(d) implement a
system for the identification of every single blood donation, every single
blood unit and components thereof, allowing full traceability to the donor as
well as to the transfusion and its recipient.
13. Information to
the Authority.– A blood
establishment shall immediately inform the Authority, in the prescribed manner,
of any serious adverse event or serious adverse reaction.
14. Data protection, etc.– (1) Every blood establishment shall
have a procedure in place to accurately, efficiently and verifiably
prevent distribution or issuance of any unhealthy blood or blood
components.
(2)
The blood establishment performing blood collection shall take all necessary
measures to ensure that all data, including genetic information, collected
under the Act to which third parties have access have been rendered anonymous
so that the donor is no longer identifiable.
(3) For the purpose, every blood
establishment performing blood collection shall ensure that:
(a) data
security measures are in place and safeguards are provided against unauthorized
data additions, deletions or modifications to donor files or deferral records
and transfer of information;
(b) procedures
are in place to resolve data discrepancies; and
(c) no unauthorized
disclosure of such information occurs, whilst guaranteeing the traceability of
donation.
15. District blood
transfusion committees.– (1) The
Government may constitute District Blood Transfusion Committees, consisting
of philanthropists, social workers and such other persons as the
Government may deem appropriate.
(2) A
Committee shall perform such functions as are assigned to it by the Authority
or as may be prescribed.
16. Registration
and licensing.– (1) A blood
establishment shall not receive or supply blood unless it is registered with
the Authority and holds a valid license issued by the Authority in such manner
and on payment of such fee as may be prescribed.
(2) The Authority may issue a provisional license to a
blood establishment in a case where the non-compliance is not critical, subject
to the condition that the blood establishment shall rectify the non-compliance
documented by the Authority within the specified time.
17. Obligation.– A
person shall:---
(a) not operate a blood
establishment unless it is registered with Authority and holds a valid license
under the Act;
(b) fully observe the provisions of
the Act or rules or regulations; and
(c) ensure that the
standards prescribed or specified by the Authority are fully implemented.
18. Offence.– The offence under the Act shall be of two kinds:---
(a) “critical offence”
which means an offence involving a serious adverse event or serious adverse
reaction;
(b) “significant offence”
means an offence falling under any of the following categories:
(i) unhygienic
premises;
(ii) inadequate
number of staff or engagement of non-qualified staff and untrained
staff;
(iii) the use
of any equipment, including the storage equipment which is not functioning
according to prescribed protocols or standing operating procedures;
(iv) non-observance
of standard operating procedures;
(v) any
equipment present in blood unit not functioning according to prescribed
temperature;
(vi) improper
display of standard operating procedures in working areas of the blood unit;
(vii) use of substandard
or expired consumable, reagent, chemical, disposal, kit, solution or
water in use of blood unit or manufactured by a non-registered manufacturer;
(viii) improper maintenance of
records regarding an inventory relatable to blood, blood products, consumables,
disposables, chemicals in use or stock, issued or used, expired, discarded,
supplied, re-deposited;
(ix) lack of
alternate source for electric supply causing interrupted functioning of cold
chain or processing in blood unit;
(x) improper
labeling of blood, blood products, blood samples with careless, incomplete,
non-legible, erasable, tampered, overwritten written or a label without
bar-coding;
(xi) improper
transportation of blood and blood products or reagent; and
(xii) lack of
separate areas for donor reception, history taking and examination, donor
bleeding, cross-matching and screening of blood in a Blood Bank.
19. Penalty.– (1) Subject to subsection (2) whoever, either
by himself or through another person, commits an offence under section 18 or
willfully contravenes any of the provisions of the Act, rules, regulations or
standards prescribed thereunder shall be punishable with imprisonment of either
description for a term which may extend to seven years and with fine which may
extend to one million rupees.
(2) Whoever,
either by himself or through another person, willfully contravenes the
provisions of clause (b) of subsection (2) of section 11 shall be liable
to fine which may extend to fifty thousand rupees but which shall not be less
than ten thousand rupees.
(3) An
offence under the Act shall be non-bailable.
20. Cognizance.– A court shall not take cognizance of an offence under the Act
except on a complaint in writing by an officer authorized by the Authority.
21. Offences by
companies.– (1) Where an offence
under this Act has been committed by a Company, every person, who at the time
of the commission of the offence, was in charge of the Company, shall be liable
to punishment for the offence and the Company shall also be liable to the
punishment of fine specified for the offence.
(2) Notwithstanding
anything contained in sub-section (1), where it is proved that the offence is
attributable to any neglect on the part of any director, manager, secretary or
other officer of the Company, such director, manager, secretary or other
officer shall also be liable to punishment for the offence.
Explanation.– In
this section, “Company” means a body corporate and includes a firm or any other
association of persons.
22. Publication of
offender's name.– The Authority
shall publish the name of any person convicted of an offence under the Act in
such manner as may be prescribed.
23. Secretariat and
employees.– (1) The head-office
of the Authority shall be at
(2) The Authority may employ, in the
prescribed manner, such officers and staff as may be necessary for the
performance of functions under the Act.
24. Fund of the Authority.– (1) The Government shall establish a Fund of
the Authority to be known as the Punjab Blood Transfusion
Authority Fund which shall vest in the Authority.
(2) The
Authority shall maintain the Fund in the prescribed manner.
(3) The Fund
shall consist of:
(a) grants received
from the Government through budgetary allocations;
(b) income received
from registration fees and license fee and all other sums received by the
Authority;
(c) money received
from the Federal Government or any international organization by way of grant,
loan, advance or others;
(d) money received
from the disposal of movable and immovable property of the Authority; and
(e) any other
money received by the Authority.
25. Accounts and Audit.– (1) The Authority shall maintain complete and
accurate books of accounts of its actual expenses and receipts in the manner
prescribed.
(2) The
Board shall approve the annual budget of the Authority in the prescribed
manner.
(3) The
accounts of the Authority shall be audited annually by the Auditor General
of
26. Delegation.– The Authority may delegate any of its
functions to the Secretary or any other officer of the Authority except the
following functions:
(a) making
of regulations;
(b) approval
of budget of the Authority in addition to the budget allocated by the
Government; and
(c) making of
policies.
27. Miscellaneous.– (1) The Act shall apply to the collection and
testing of blood and blood components, and to their processing, storage,
distribution, issuance and use but it shall not apply to blood stem cells.
(2) The
Authority may allow import into or export from the
(3) The
following principles shall also be followed with regard to the blood
transfusion process:
(a) blood
donation shall be a voluntary, anonymous and non-remunerated act;
(b) transfusion
is a not-for-profit health sector activity;
(c) implementation
of a common set of standards across blood establishments shall ensure an
equivalent level of quality and safety of blood and blood components in the
Punjab, regardless of the source; and
(d) self-sufficiency in
blood and blood components and its rational and optimal use in compliance with
modern good clinical practices shall be the priority of the Government.
(4) A person shall not perform blood
transfusion therapy unless it is prescribed and performed under a physician's
responsibility and surveillance and may only be performed in licensed medical
institution.
28. Immunity.– No suit or other legal proceedings shall be instituted against
the members, officer or officials of the Authority for any actions taken in
good faith under the Act.
29. Power to
make rules.– The Government may,
by notification in the official Gazette, make rules to carry out the purposes
of the Act.
30. Power to make
regulations.– Subject to the Act
and the rules, the Authority may, by notification in the official Gazette,
frame regulations to give effect to the provisions of the Act.
31. Repeal.– The Punjab Transfusion of Safe Blood
Ordinance, 1999 (XXXVI of 1999) is hereby repealed.
[1]This Act was passed by the Punjab Assembly on 19
October 2016; assented to by the Governor of the
Go to Index | LL. B. – I | LL. B. – II | LL. B. – III | LL. B. Directory | Home